Efficacy and Safety Evaluation of Traditional Chinese Medicine in the Treatment of Advanced Colorectal Cancer

NCT02923622 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 384

Last updated 2016-10-04

No results posted yet for this study

Summary

Although patients of colorectal cancer use Traditional Chinese Medicine (TCM) herbal therapy extensively in China, no strong evidence exists to demonstrate the safety and survival outcomes of TCM herbal therapy combined with conventional western medicine for treatment of this disease. The purpose of this multi-center perspective cohort study is to evaluate the relationship between TCM herbal therapy and survival outcomes in patients with advanced colorectal cancer.

Conditions

  • Advanced Colorectal Cancer
  • Traditional Chinese Medicine

Interventions

OTHER

Traditional Chinese medicine herbals

TCM herbal treatment based on TCM syndrome differentiation,without any anti tumor therapy in Western Medicine

OTHER

Integrated traditional Chinese and Western medicine

TCM herbal treatment combine with anti tumor therapy in Western Medicine ( including non recommended chemotherapy, radiotherapy and targeted therapy in clinical guidelines)

OTHER

Western medicine

Anti tumor therapy in Western Medicine ( including non recommended chemotherapy, radiotherapy and targeted therapy in clinical guidelines)

Sponsors & Collaborators

  • Beijing Municipal Science & Technology Commission

    collaborator OTHER
  • Xiyuan Hospital of China Academy of Chinese Medical Sciences

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2020-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02923622 on ClinicalTrials.gov